Vibrenta is indicated to enhance glycemic control in adults and children with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Vibrenta Penset is a long-acting insulin used to manage both type 1 and type 2 diabetes mellitus in adults and children. It provides sustained insulin levels throughout the day to control blood sugar and prevent complications of diabetes. It can be used alone or in combination with fast-acting insulin or other diabetes medications.
Consuming alcohol with Vibrenta Penset is unsafe and can lead to adverse effects, particularly by lowering blood sugar levels unpredictably. It's advisable to avoid alcohol consumption while using this medication.
Vibrenta Penset may pose risks during pregnancy. Although limited human studies are available, animal studies indicate potential harm to the developing baby. Your doctor will assess the benefits versus risks before prescribing this medication during pregnancy. Consult your doctor if you are pregnant or planning pregnancy.
Vibrenta Penset is considered safe during breastfeeding. Human studies suggest minimal excretion into breast milk, posing little risk to the nursing infant. Nevertheless, consult your doctor before using this medication while breastfeeding.
Fluctuations in blood sugar levels (both high and low) can affect your ability to drive. Avoid driving if you experience symptoms of low or high blood sugar levels such as weakness, dizziness, or confusion.
Use Vibrenta Penset cautiously if you have kidney disease. Dose adjustments may be necessary. Regular monitoring of blood glucose levels is recommended for appropriate dose adjustments.
Patients with liver disease should also use Vibrenta Penset with caution. Dose adjustments may be required based on regular monitoring of glucose levels. Consult your doctor for personalized guidance.
Diabetes mellitus
Vibrenta Penset mimics natural insulin action in the body, facilitating glucose uptake into muscle and fat cells while suppressing liver glucose production.
Possible side effects include hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, itching, and rashes.
Vibrenta is prescribed to improve glycemic control in both adults and children with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
Insulin Glargine is a sterile solution used for subcutaneous injection. It is a long-acting (up to 24 hours) human insulin analog produced through recombinant DNA technology. Its primary function is to regulate glucose metabolism. It lowers blood glucose by stimulating peripheral glucose uptake, mainly by skeletal muscle and fat, and by inhibiting hepatic glucose production. Insulin also inhibits lipolysis and proteolysis and enhances protein synthesis.
Insulin Glargine should be administered once daily at the same time each day. Dosages are personalized based on clinical response, with regular blood glucose monitoring essential. For Type 1 diabetes, it must be combined with short-acting insulin. It is not suitable for intravenous administration as it may cause severe hypoglycemia.
Starting Therapy:
Converting from Other Insulin Therapies:
Cartridge: Insert into the pen, attach the needle, and mix the insulin by gently turning the pen upside down 8-10 times. Adjust dosage, remove the needle cap, expel air bubbles, and inject.
Various drugs affect glucose metabolism, potentially requiring dose adjustments.
Drugs that may reduce requirements:
Drugs that may increase requirements:
It is not for use in patients hypersensitive to insulin galline or its ingredients.
Classified as Pregnancy Category C. Use during pregnancy only if benefits outweigh risks. The excretion in human milk is unknown, so caution is advised for nursing women, with potential dose and dietary adjustments needed.
Dose Adjustment and Monitoring: Regular monitoring of blood glucose is necessary. Adjustments should be made under medical supervision.
Administration: Do not dilute or mix with other insulins or solutions. Not for use in insulin pumps or intravenously due to hypoglycemia risk.
Renal or Hepatic Impairment: Dose reductions may be necessary.
Store between 2°C and 8°C in a refrigerator. Do not freeze and protect from light.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.